Screening for syphilis infection in pregnancy: U.S. Preventive Services Task Force reaffirmation recommendation statement

U.S. Preventive Services Task Force

doi:10.7326/0003-4819-150-10-200905190-00008

Screening for syphilis infection in pregnancy: U.S. Preventive Services Task Force reaffirmation recommendation statement

Ann Intern Med. 2009 May 19;150(10):705-9. doi: 10.7326/0003-4819-150-10-200905190-00008.

Author

U.S. Preventive Services Task Force¹

Collaborators

U.S. Preventive Services Task Force:
Ned Calonge, Diana B Petitti, Thomas G DeWitt, Allen Dietrich, Kimberly D Gregory, David Grossman, George Isham, Rosanne Leipzig, Lucy N Marion, Bernadette Melnyk, Virginia A Moyer, Judith K Ockene, George F Sawaya, J Sanford Schwartz, Timothy Wilt

Affiliation

¹ U.S. Preventive Services Task Force, Agency for Healthcare Research and Quality, Rockville, Maryland, USA.

PMID: 19451577
DOI: 10.7326/0003-4819-150-10-200905190-00008

Abstract

Description: Update of the 2004 U.S. Preventive Services Task Force statement about screening for syphilis in pregnancy.

Methods: The U.S. Preventive Services Task Force did a targeted literature search for evidence on the benefits of screening, the harms of screening, and the harms of treatment of syphilis with penicillin during pregnancy.

Recommendation: Screen all pregnant women for syphilis infection. (Grade A recommendation.).

Publication types

Practice Guideline
Research Support, U.S. Gov't, P.H.S.

MeSH terms

Anti-Bacterial Agents / adverse effects
Anti-Bacterial Agents / therapeutic use
False Positive Reactions
Female
Humans
Infant, Newborn
Mass Screening* / adverse effects
Penicillin G Benzathine / adverse effects
Penicillin G Benzathine / therapeutic use
Pregnancy
Pregnancy Complications, Infectious / diagnosis*
Pregnancy Complications, Infectious / drug therapy*
Risk Assessment
Syphilis / diagnosis*
Syphilis / drug therapy*
Syphilis, Congenital / prevention & control*
Time Factors

Substances

Anti-Bacterial Agents
Penicillin G Benzathine